InsidersTradesSigma
Follow the 대한약품 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 대한약품 has recorded 140 public disclosures. The latest transaction was filed on 31 August 2026 (Purchase). Among the most active insiders: 이윤우. Every trade is free.
140
Insider Decl.
n/a
Thresholds
€15,521
63 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 August 2026
Declarations140 total
25 of 140 declarations
Acerca de 대한약품
대한약품 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se especializa en la fabricación de productos farmacéuticos y medicamentos.